The key questions you should be asking when deploying AR/VR

14 July 2023
Steve Zartarian
Account Manager

Extended reality (XR) is a term used to encompass different types of immersive technologies that integrate both digital and physical environments. It includes augmented reality (AR), virtual reality (VR), and mixed reality (MR).

XR applications are often linked to home entertainment and gaming but are becoming more common in various industries, including healthcare and biopharma. This is especially so since our industry is on a journey to increase and improve its digitization, e.g., in training, lab spaces, and manufacturing.

However, when implementing this technology in GxP environments, the risks associated with deployment must be carefully thought through.

This focus on risks is why we have written AR-VR: Risk considerations for the implementation of extended reality solutions within a GxP environment in the biopharma industry.

Get set up for success

“Augmented reality has the potential to transform the pharma industry and add tremendous value to the shop floor,” said Georgios Chantziaras, Senior Associate – Smart Factory Technology at Pfizer. “But we need to make sure we are set up for success by taking into consideration all the risks that come with emerging technologies.”

Our paper gives you risk considerations in different categories based on your organization’s appetite for risk, local country laws, company policies, and IT hardware/software standards. These cover regulatory, business, technology, and safety, health, and environmental risks. We do not cover every risk in each scenario, but we help define the types of risks that should be taken into account.

For each category, risk/impact statements provide context for the risks you should look at – these are not intended to replace traditional risk assessment but to support that process.

The statements are followed by questions that readers can use to guide risk discussions in that category. For example, under ‘regulatory risk’, questions include, what is and what is not considered GxP data in the system? And how will data integrity be maintained for GxP records?

The paper’s target audience is not just IT groups but also the teams that will be using this new technology – and those who are being asked to sign-off any investment. While AR/VR implementations are often seen as IT projects, business and technology risks are covered because collaboration with the business teams impacted by the new technology is essential. It will help them review the crucial issues when developing the technology internally or implementing an off-the-shelf product.

“To capture the value of these recent technologies, the industry needs to understand them and their associated risks,” said Jonathan MacDonnell, Director Digital Transformation – Group Operations at Lonza. “This paper brings together the pioneering AR/VR experiences of leading biotech companies and will help guide further investment decisions for AR/VR in our regulated industry.” For more information, download the paper here . If you have any real-life experiences of implementing XR technologies in your business and would like to share them, please get in touch with Steve Zartarian, Global Change Facilitator, at

Woman with VR Set
Driving collaboration to unleash the power of AR/VR in the biopharmaceutical manufacturing environment

Advanced Therapy Medicinal Products

Advanced Therapy Medicinal Products support the quest for better and faster development of cell, gene and RNA therapies​ through connecting therapy developers, contract manufacturing, and testing organizations to gain an understanding and respond to the challenges faced by the advanced therapeutics industry.

Development Group

Development Group accelerates and improves the development process of biopharmaceutical medicines for the benefit of the patient. Replacing isolation with collaboration by providing a “safe” space where subject matter experts can work on sharing solutions and best practice on emerging industry trends, implementation of new technologies and common issues whilst ensuring their intellectual property and confidentiality is protected.

Drug Substance

Drug Substance advances excellence in drug substance manufacturing and testing, acting as an industry voice to accelerate technology adoption, implement post-approval change more rapidly and increase confidence in maintaining compliance.

Fill Finish

Fill Finish accelerates development and acceptance of sustainable world-class filling and packaging operations for drug product which meets the future needs of patients. Through innovative solutions resulting from the sharing of expertise, we can overcome common performance challenges and deliver on quality and regulatory compliance.

Information Technology

Information Technology accelerates digital maturity across the ​global pharmaceutical manufacturing industry.


BioPhorum Quality provides a dedicated, safe space for quality professionals from biomanufacturers and contract organizations to coalesce and enhance effective collaboration to address shared industry challenges.


Regulatory CMC brings leaders together who have a common goal – to improve access to medicines through innovation in the Regulatory ecosystem. It provides a dedicated space for strategic leadership and a coordinated industry voice, to move from divergence to convergence.

Supply Chain to Patient

Supply Chain to Patient transforms the performance of global pharmaceutical clinical and commercial outbound supply chains through industry collaboration by creating transparent patient-centric, resilient and agile E2E supply chains, that consistently deliver high-quality medicines ensuring an uninterrupted supply to patients.

Supply Partner

Supply Partner is a trusted advisory group and collaboration that is the engine for driving change across the global industry for all things relevant to the inbound supply chain. Addressing the challenges of complexity, resilience, cost, sustainability, and innovation.


Sustainability enables the industry’s transition to a low carbon, circular future – supporting members to improve patient health while respecting the planet. We activate multi-disciplinary teams drawn from our network to deliver environmental sustainability improvements across the value chain.

Technology Strategy

Technology Strategy acts as one voice of the industry to define strategy, accelerate technology transformation and support technology translation and adoption. With a purpose of enabling the future state of flexible, resilient, sustainable end-to-end biomanufacturing.

An industry perspective on understanding AAV capsid content variants
Needle On Yellow Background
An intercompany perspective on practical experiences of predicting, optimizing and analyzing high concentration biologic therapeutic formulations
The Drug Substance 2.0 Strategic Value Framework
Coloured dots on teal, next to vial
BioPhorum’s holistic approach to container closure integrity
Magnifying glass over a tablet all coloured blue
Digital Plant Maturity Model 3.0
Investigation Digital Workstreams
Peer to peer practical guidance on remote inspections and audits
The next step in building regulatory as a capability to enable strategic innovation across the BioPhorum community
BioPhorum roundals on sugical gloves
A visionary strategic framework for future patient-centric outbound biopharmaceutical supply chains
DNA and Earth on blue background
A vision for the biopharmaceutical industry’s inbound supply chain
Lightbulb And Icons On Colourful Background
BioPhorum environmental sustainability roadmap 2022
Technology Roadmap V 2.0
BioPhorum Technology Roadmapping roadmap vision 2.0


Documents including best practices, vision statements and peer reviewed papers to help you take value back to your business.


Discussing all aspects of the biopharmaceutical industry, from digitization and knowledge management to raw materials, supply chain, sustainability and more. Learn from the perspectives of those at the forefront of the industry.


BioPhorum Connect is our podcast series that keeps you up to date with the latest news and trends in the biopharmaceutical industry. From experienced professionals to thought leaders, these podcasts bring you the insights and perspectives of experts from around the world.


A variety of resources including design tools and user requirement specifications to help you improve and streamline your business processes.

Benchmarks and Surveys

Research conducted among the BioPhorum membership providing evidence to support change and identify best practice.

Browse all

Access a variety of free tools and papers and other resources designed to provide you with up-to-date information and insights to help you make informed decisions and maximize your success. Access our resources today and start making improving and streamlining your business processes.

Bioreactivity testing in single-use system biomanufacturing
Bioreactivity testing in single-use system biomanufacturing
Bioreactivity testing in single-use system biomanufacturing
Magnifying glass over a tablet all coloured blue
Digital Plant Maturity Model 3.0
Bioreactivity testing in single-use system biomanufacturing